Jean Dausset | Academic Influence

Jean Dausset's AcademicInfluence.com Rankings

Jean Dausset

Biology

#225

World Rank

#412

Historical Rank

Immunology

#27

World Rank

#30

Historical Rank

biology Degrees

Download Badge

Biology

Jean Dausset's Degrees

Doctorate Medicine Université Paris Cité
Doctorate Immunology Université Paris Cité

Why Is Jean Dausset Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jean-Baptiste-Gabriel-Joachim Dausset was a French immunologist born in Toulouse, France. Dausset received the Nobel Prize in Physiology or Medicine in 1980 along with Baruj Benacerraf and George Davis Snell for their discovery and characterisation of the genes making the major histocompatibility complex. Using the money from his Nobel Prize and a grant from the French Television, Dausset founded the Human Polymorphism Study Center in 1984, which was later renamed the Foundation Jean Dausset-CEPH in his honour. He married Rose Mayoral in 1963, with whom he had two children, Henri and Irène. Jean Dausset died on June 6, 2009, in Majorca, Spain, at the age of 92.

(See a Problem?)

Jean Dausset's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Human Genome Diversity Cell Line Panel (2002) (987)
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. (1997) (691)
Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. (1990) (583)
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. (1998) (440)
Iso-leuco-anticorps (1958) (426)
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. (1999) (424)
Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. (1990) (378)
HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS (1974) (364)
HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. (2003) (356)
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? (1997) (345)
HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis1 (2001) (336)
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism (2001) (327)
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. (2000) (316)
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. (1999) (316)
HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. (2004) (310)
The Major Histocompatibility Complex in Man (1981) (273)
Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection (2002) (240)
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. (1994) (233)
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death (2001) (232)
Implication of HLA-G molecule in heart-graft acceptance (2000) (224)
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma (1981) (196)
Maternal traces of deep common ancestry and asymmetric gene flow between Pygmy hunter–gatherers and Bantu-speaking farmers (2008) (194)
Fetal DNA in skin of polymorphic eruptions of pregnancy (1998) (192)
HLA-G inhibits the allogeneic proliferative response. (1999) (190)
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. (2001) (190)
Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer (2002) (183)
Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway (2008) (181)
Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression (1998) (179)
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells (1980) (177)
Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule (2002) (177)
Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease (2001) (173)
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. (2001) (166)
Letter: Histocompatibility determinants in multiple sclerosis. (1974) (164)
Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. (2003) (159)
HLA-G gene repression is reversed by demethylation (2003) (152)
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. (1999) (151)
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells (1978) (145)
Probable Haploid Expression of HL-A Antigens on Human Spermatozoon (1970) (141)
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. (1981) (140)
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. (2000) (136)
Antibody‐induced redistribution of HL‐A antigens at the cell surface (1972) (135)
Leukoagglutinins. V. Leukoagglutinins in chronic idiopathic or symptomatic pancytopenia and in paroxysmal nocturnal hemoglobinuria. (1954) (129)
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. (1985) (128)
Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients (2004) (127)
HLA-G: a tolerance molecule from the major histocompatibility complex. (1999) (125)
SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). (1999) (123)
HLA-G revisited. (1996) (122)
A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β* (2001) (118)
Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics (2007) (116)
Dense Alu clustering and a potential new member of the NFκB family within a 90 kilobase HLA Class III segment (1993) (111)
Decline of natural killer cell activity in sublethally irradiated mice. (1978) (111)
A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. (1978) (111)
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. (1996) (109)
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene (2007) (107)
Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn). (1959) (105)
The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase (2003) (104)
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations (1987) (103)
The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. (1959) (101)
Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. (1995) (99)
A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. (2001) (96)
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. (1984) (96)
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. (2004) (94)
Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines (2000) (94)
HLA and Susceptibility to Hodgkin's Disease (1983) (91)
Genetics of HLA disease association. (1981) (90)
Spontaneous retinopathy in HLA-A29 transgenic mice (2001) (88)
HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. (2008) (84)
Mixed lymphocyte reactivity of human lymphocytes primed in vitro. I. Secondary response to allogenic lymphocytes (1975) (83)
The immunotolerance role of HLA-G. (1999) (83)
Modulation of HLA-G expression in human thymic and amniotic epithelial cells. (2000) (82)
Clusters of HLA class II beta restriction fragments describe allelic series. (1984) (79)
HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. (2000) (79)
A STUDY OF HL-A ANTIGENS IN HUMAN ORGANS (1970) (79)
Tissue alloantigens in humans: identification of a complex system (Hu-1) (1966) (79)
HLA‐G in Transplantation: A Relevant Molecule for Inhibition of Graft Rejection? (2003) (79)
Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. (2004) (78)
Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women (1997) (78)
Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. (2001) (78)
A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families (2000) (77)
Depression of immunologic reactivity of patients with acute leukemia (1971) (77)
Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets. (1961) (75)
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression. (1992) (74)
Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. (1999) (73)
The association of the HL-A antigens with diseases. (1974) (73)
Some Contributions of the HL‐A Complex to the Genetics of Human Diseases (1975) (71)
Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types. (1999) (71)
HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. (1982) (70)
Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group. (1974) (65)
HLA antigen in three types of glomerulonephritis. (1978) (64)
Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure (2006) (63)
HLA-G expression in human melanoma cells: protection from NK cytolysis. (1999) (60)
Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. (2000) (58)
A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques (2008) (55)
BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. (1994) (53)
Le centre d'étude du polymorphisme humain. (1986) (52)
DNA Polymorphism of HLA Class I and Class II Regions (1985) (52)
Analysis of the role of HLA-G in preeclampsia. (2000) (52)
HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. (1982) (51)
Journal of Biomedicine and Biotechnology (2001) (50)
HUMAN TRANSPLANTATION ANTIGENS: THE HL‐A (Hu‐1) SYSTEM AND ITS HOMOLOGY WITH THE MOUSE H‐2 SYSTEM (1968) (50)
The localization of the Bf locus within the MHS region on chromosome no. 6. (2008) (49)
p21WAF-1 reorganizes the nucleus in tumor suppression. (1998) (49)
The CEPH YAC library. (1992) (48)
The Mixed Antiglobulin Reaction in the Detection of Human Iso‐Antibodies against Leucocytes, Platelets and HeLa Cells (1959) (47)
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. (1981) (47)
[Acquired hemolytic anemia with polyagglutinability of erythrocytes by a new factor present in normal blood]. (1957) (46)
Immunoferritin study of the distribution of HL-A antigens on human blood cells. (1971) (46)
HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. (1988) (45)
IMMUNOLOGICAL STUDIES IN PATIENTS WITH PLACENTAL CHORIOCARCINOMA. (1964) (44)
HLA-G 1-expressing antigen-presenting cells induce immunosuppressive CD 4 T cells (2004) (44)
HLA monoclonal antibody registry: a proposal. (2008) (44)
The HL-A system sub-loci and their importance in transplantation. (1969) (44)
Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody. (1995) (44)
HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS (1971) (43)
In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients (2006) (43)
Cloning the human major histocompatibility complex in YACs. (1994) (43)
Nomenclature for factors of the HLA system, 1984. (1984) (43)
Studies on the Biosynthetic Pathway of Human P Erythrocyte Antigens Using Somatic Cells in Culture (1974) (43)
Audiovisual documentation of oral consent: a new method of informed consent for illiterate populations (2002) (42)
Iso‐Leuko‐Antibodies * (1958) (42)
Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. (1983) (41)
BIOLOGICAL AND ULTRASTRUCTURAL STUDIES OF LEUCOCYTE FRACTIONS AS TRANSPLANTATION ANTIGENS IN MAN (1965) (41)
Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. (2001) (41)
HLA-G gene polymorphism segregation within CEPH reference families (1997) (40)
Letter: HL-A antigen W27--a genetic link between ankylosing spondylitis and Reiter's syndrome? (1974) (40)
Nomenclature for factors of the HL-a system. (1998) (40)
HLA-G expression: immune privilege for tumour cells? (1999) (39)
Idiopathic hemochromatosis: linkage with HLA. (1978) (39)
LEUKOCYTE ANTIGENS AND SKIN HOMOGRAFT IN MAN. DEMONSTRATION OF HUMORAL ANTIBODIES AFTER HOMOGRAFTING BY THE ANTIGLOBULIN CONSUMPTION TEST * (1964) (38)
Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8. (1983) (38)
HLA- and H-2-associated variations of intra- and extracellular magnesium content. (1990) (38)
[The Center for the Study of Human Polymorphism]. (1986) (37)
Is the MHC a general self-recognition system playing a major unifying role in an organism? (1980) (37)
THE ROLE OF BLOOD GROUP ANTIGENS IN HUMAN HISTOCOMPATIBILITY * (1966) (36)
HLA-DR genotype risks in seropositive rheumatoid arthritis. (1984) (36)
Élimination de certains chocs transfusionnels par l'utilisation de sang appauvri en leucocytes * (1957) (36)
Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders. (1996) (36)
Theoretical analysis of a physical mapping strategy using random single-copy landmarks. (1991) (36)
Immunotolerant functions of HLA-G (1999) (36)
Serologic factors in human transplantation. (1967) (35)
Immune Platelet Iso‐Antibodies (1960) (35)
The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroup (1988) (35)
Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro. (1986) (34)
The relation of parental sex and age to recombination in the HL-A system. (1973) (34)
Drug-induced hemolysis. (1967) (34)
CELLULAR AND HUMORAL RESPONSE AGAINST DETERMINANTS OTHER THAN THE CLASSICAL HL‐A SPECIFICITIES: EVIDENCE FOR AT LEAST ONE SYSTEM INDEPENDENT OF THE MAJOR HISTOCOMPATIBILITY COMPLEX (1974) (34)
The genetics of transplantation antigens. (1971) (34)
HLA and multiple sclerosis: population and families study. (2008) (33)
Lymphocyte Stimulation by Soluble Human HL-A Transplantation Antigens (1968) (33)
Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood. (1995) (33)
Use of a variable alpha region to create a functional T-cell receptor delta chain. (1988) (33)
Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped families. (1973) (32)
European Gene Mapping Project (EUROGEM): Genetic Maps based on the CEPH reference families (1994) (32)
HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. (1997) (32)
HLA-G promotes immune tolerance. (2000) (31)
Studies of human alloantigens on man‐mouse hybrids: possible syntheny between hl‐a and p systems (1973) (31)
HLA-G protein processing and transport to the cell surface (2002) (31)
Identical Nature of the Leucocyte Antigens detectable in Monozygotic Twins by means of Immune Iso-Leuco-agglutinins (1957) (31)
Transplantation Antigen Activity Of Human Blood Platelets1 (1966) (30)
Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases. (1978) (29)
Correlation between histocompatibility antigens and susceptibility to illness. (1972) (29)
Subsets of malignant lymphomas in children related to the cell phenotype (1979) (29)
Human leukocyte antigen–C in short‐ and long‐term liver graft acceptance (2003) (28)
Serological and Genetic Studies of the HL‐A System (1971) (28)
Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules. (1987) (28)
HLA-DR specific human suppressor lymphocytes generated by repeated in vitro sensitisation against allogeneic cells (1978) (28)
Viewpoint on the Functionality of the Human Leukocyte Antigen-G Null Allele at the Fetal-Maternal Interface (2002) (28)
Definition in man of a polymorphic system of the normal colonic secretions. (2008) (28)
The complexity of the HL-A gene product. II. Possible evidence for a "public" determinant common to the first and second HL-A series. (1975) (27)
Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. (1999) (27)
Polymorphism of HLA-G gene and protein. (1999) (27)
HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS (1971) (27)
Genotyping with DNA probes in combined immunodeficiency syndrome with defective expression of HLA. (1985) (27)
History of Hla Ten Recollections (1990) (26)
LOWER NEPHRON NEPHROSIS: Report of Treatment of Forty-Four Patients by Repeated Replacement Transfusions (1950) (26)
Role of ABO Erthrocyte Groups in Human Histocompatibility Reactions (1966) (26)
DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy (2004) (26)
Hemagglutination by Human Anti‐Leukocyte Serums (1967) (25)
Subsets of malignant lymphomas in children related to the cell phenotype. (1979) (25)
In vivo, RFX5 binds differently to the human leucocyte antigen‐E, ‐F, and ‐G gene promoters and participates in HLA class I protein expression in a cell type‐dependent manner (2004) (25)
Microchimerism in human diseases. (2000) (25)
A "natural" anti-HLA-A2 antibody reacting with homozygous cells. (2008) (25)
HLA at the Gene Level (1984) (25)
Allo‐Antigens and Antigenic Factors of Human Leukocytes: A Hypothesis (2009) (24)
Idiotypic induction and immune networks (1980) (24)
PROPERDIN FACTOR B ALLELES AS MARKERS FOR INSULIN-DEPENDENT DIABETES (1979) (24)
On the heterogeneity of linkage estimations between LA and four loci of the HL-A system,. (2008) (23)
Critical evaluation of histocompatibility in 179 renal transplants. (1971) (23)
Studies of skin allograft survival and mixed lymphocyte culture reaction in Hl-A-genotyped families. (1972) (23)
Leucocyte and Platelet Groups and their Practical Significance * (1965) (22)
Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones. (1985) (22)
Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. (1989) (22)
Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens. (1968) (22)
ADCC as primary mechanisms of defence against metazoan parasites. (1980) (22)
Cytotoxic reactions of anti-H-2 sera with human lymphocytes. (1972) (21)
Test direct de consommation de l'antiglobuline sur les leucocytes et les plaquettes de certains malades atteints de pancytophnies idiopathiques * (1958) (21)
Exuberant restriction fragment length polymorphism associated with the DQ alpha-chain gene and the DX alpha-chain gene. (1985) (21)
HLA markers and lymphocytotoxins in lichen planus. (1977) (20)
The required interaction between monocytes and peripheral blood T lymphocytes (T‐PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T‐PBL subsets (1988) (20)
HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs. (1980) (20)
A LEUCOCYTE GROUP AND ITS RELATIONSHIP TO TISSUE HISTOCOMPATIBILITY IN MAN (1965) (20)
Étude d'un anticorps allergique actif en présence de para‐amino‐salicylate de soude (PAS) contre les hématies, les leucocytes et les plaquettes humaines * (1961) (20)
[HLA and disease]. (1978) (20)
A simplified method for freezing lymphocytes in nitrogen vapors. (1973) (20)
A centromere-based genetic map of the short arm of human chromosome 6. (1991) (20)
The complexity of the HL-A gene product I: study of a serum produced against HL-A5 in an HL-A semi-identical situation. (2008) (20)
HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells. (1988) (20)
Biologie moleculaire et medecine (1993) (20)
Présence de l'antigène Rh (D) dans les leucocytes et les plaquettes humaines (1958) (20)
[The Hu-1 system]. (1967) (20)
Allo-Antigens and Antigenic Factors of Human Leukocytes (1966) (19)
Induction of HLA expression in Daudi cells after cell fusion (1977) (19)
Different stimulating capacity of B and T lymphocytes in primary and secondary allogeneic reactions: cellular detection of HLA-D products on T lymphocytes. (1980) (19)
Isolation of a human major histocompatibility complex class I gene encoding a nonubiquitous molecule expressed on activated lymphocytes. (1987) (19)
Nomenclature for factors of the HLA system--1977. (1978) (19)
Leukocyte Antigens and the Mixed Lymphocyte Culture Reaction (1967) (19)
Genetic and biological aspects of the HL-A system of human histocompatibility. (1970) (18)
HLA-G: Public ligand for natural killer cell inhibitory receptors (1997) (18)
Human migrations and linkage disequilibrium ofHL-A system (1974) (18)
Role of MLC locus and related genes of the chromosomal HL-A region. (1973) (18)
Cell-mediated cytotoxicity toward human lymphocytes: comparison between in vivo immunization and in vitro sensitization. (1973) (18)
GENETICS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX (1976) (18)
Transplantation antigen activity of human blood platelets. (1966) (18)
Analysis of 221 renal transplants: influence of cross-reactions between donor and recipient HL-A antigens. (1971) (17)
Two Cases of Neo‐Natal Thrombocytopenia due to Maternal Iso‐Immunization Against Leuco‐Platelet Antigens (1968) (17)
MLR in families with an HL-A haplotype shared by parents: recombination between SD2 and LD2 and possible evidence for an LD3 locus. (1973) (17)
First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination (1986) (17)
Combined analysis of three studies of patients with Burkitt's lymphoma. (2008) (17)
MONOCYTOTOXIC ANTIBODIES AFTER BONE MARROW TRANSPLANTATION IN APLASTIC ANEMIA (1982) (17)
Un nouvel exemple d'anticorps anti‐plaquettaire KO (1963) (17)
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. (1979) (17)
AUTO‐ANTILEUKOCYTE RIBOSOMAL FRACTION IN LEUKONEUTROPENIAS (1965) (17)
Support for genetic diversity project (1997) (17)
Allo‐Antigens and Allo‐Antibodies of the Ko System, Serological and Genetic Study (1973) (17)
Biologic role of the HLA system. HLA complex in human biology in the light of associations with disease. (1977) (16)
The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors. (2000) (16)
[HLA A-B and DR in dilated myocardiopathies]. (1987) (16)
The agglutination mechanism of trypsin modified red cells. (1952) (16)
HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms. (1986) (16)
[The sub-loci of the HL-A system. The main system of histocompatibility in man]. (1969) (16)
Tolérance fœtomaternelle : rôle de la molécule HLA-G dans la protection du fœtus contre l'activité natural killer maternelle (1997) (16)
Suppression of the human allogenetic response in vitro with primed lymphocytes and suppressive supernates. (1980) (15)
Chimerism in scleroderma (1998) (15)
SEPARATION OF HL-A TRANSPLANTATION ANTIGEN SPECIFICITIES (1970) (15)
Cell surface interaction between HL-A antigen determinants. (1971) (15)
The HLA adventure. (1999) (14)
Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. (1998) (14)
The mixed lymphocyte reaction: selective activation and inactivation of the stimulating cells. (1975) (14)
HLA and association with malignancy: a critical view. (1977) (14)
T cell dependent effects in parasitic infection and disease. (1980) (14)
Genetics of the HL-A system. (1970) (14)
Serological study of an allergic agranulocytosis due to noramidopyrine. (1968) (14)
ANTI‐B CELL LYMPHOCYTOTOXIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS (1978) (14)
A Lymphocyte Immunogenetic System, Atri, Associated with the ABO Blood Group and the ABH Secretor System (1976) (14)
Human HL-A transplantation antigens: separation of molecules carrying different immunological specificities determined by a single genotype. (1968) (13)
Role of HLA-G in maternal-fetal immune tolerance. (1999) (13)
HLA-G gene polymorphism segregation within CEPH reference families. (1997) (13)
Blood transfusions suppress lymphocyte reactivity in uremic patients. II. Evidence for soluble suppressor factors. (1983) (12)
[Alpha genes of the T cell receptor: a possible implication in genetic susceptibility to multiple sclerosis]. (1987) (12)
Two DR beta allelic series defined by exon II-specific synthetic oligonucleotide genomic hybridization: a method of HLA typing? (1986) (12)
HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis. (1994) (12)
Nomenclature for factors of the HLA system--1977. (1977) (12)
[PYRAMIDON AGRANULOCYTOSIS. AN IMMUNOHEMATOLOGICAL STUDY]. (1964) (12)
Modes de vie et cancers (1988) (12)
Progress of HLA-G in cancer. (2003) (12)
[Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term]. (1995) (12)
Statistics of 416 consecutive kidney transplants in the France Transplant organization. (1973) (12)
Letter: HL-A antigens and immune deficiency states. (1974) (12)
In Vitro Approach to a Correlation of Cell Susceptibility to Viral Infection with HL-A Genotypes and Other Biological Markers 1 (1972) (11)
Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G. (1995) (11)
Mixed lymphocyte cultures (MLC) between serologically HL-A-identical parent and child and between HL-A homozygous and heterozygous individuals. (1973) (11)
The “Sardinian”HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the21-OHA andC4B genes. Is it an ancestral haplotype without duplication? (2006) (11)
Genetic mapping of three human homologues of murine t-complex genes localizes TCP10 to 6q27, 15 cM distal to TCP1 and PLG. (1992) (11)
PRESENCE OF SLA AND Ia‐LIKE ANTIGEN ON BOAR SPERMATOZOA (1978) (11)
Iso-anticorps anti-leucocytaires et anti-plaquettaires Sérologie et importance pratique en particulier pour les greffes (1962) (11)
Immunogenetics of insulin-dependent juvenile diabetes. (1984) (11)
HL-A antigens and idiopathic autoimmune hemolytic anemias. (1974) (11)
The Genetics of the HL‐A System and its Implications in Transplantation 1 (1971) (11)
A Case of Haemolytic Anaemia due to Phenacetin Allergy (1964) (11)
[Insulin-dependent diabetes and HLA]. (1979) (11)
The heterogeneity and functional capacities of human thymocyte subpopulations. (1984) (11)
Facilitation of Skin Allograft Survival by Blood Leucocyte Extracts: A Possible Mechanism for the Beneficial Effects of Blood Transfusion in Human Transplantation (1984) (11)
Les Thrombo-Anticorps (1958) (11)
[Presence of leuko-agglutinin in the serum of a case of chronic agranulocytosis]. (1952) (10)
Close genetic relationships between determinants of the HLA-D region detected by MLR-I, MLR-II, and B-lymphocyte serology. (1978) (10)
Nomenclature for factors of the HLA system--1977. (1978) (10)
RETROSPECTIVE LEUKOCYTE TYPING OF UNRELATED HUMAN DONOR-RECIPIENT PAIRS IN RELATION TO SKIN ALLOGRAFT SURVIVAL TIMES: A STUDY OF 17 WELL DEFINED SPECIFICITIES (1969) (10)
Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases. (1975) (10)
HL-A phenotype and anti-RhO(D) immunization. (1974) (10)
Detection by Three Cellular Immunological Techniques of the Antigenic Determinants of the Ly‐Li System, Expressed on Human B Lymphocytes (1977) (10)
Activity of the ABO antigen system as a determinant of histocompatibility in human transplantation. (1987) (10)
Association of class II HLA-Dβ chain DNA restriction fragments with multiple sclerosis (2004) (10)
Tissue alloantigens and transplantations (1966) (10)
The B-lymphocyte Ly-Li system. (1977) (10)
Les iso-anticorps anti-plaquettaires décelés par fixation du complément (1964) (10)
Predictive medicine. (1998) (10)
HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters (2004) (10)
Detection of HLA‐D Clusters Using Primed LD Typing (1977) (10)
Les facteurs Gm(a), Gm(b), Gm(x) au cours des leucoses (1962) (10)
The Birth of MAC (1984) (10)
Les systemes d'histocompatibilite et la susceptibilite au cancer. (1968) (9)
[Histocompatibility systems and susceptibility to cancer]. (1968) (9)
Analysis of stimulating products involved in primary and secondary allogenic proliferation in man (1978) (9)
CONCENTRATION OF TRANSPLANTATION ANTIGENS IN HUMAN ORGANS (1968) (9)
Nonradioactive screening of glucokinase mutations in maturity onset diabetes of the young. (1994) (9)
Histocompatibility studies in haploidentical genetic combinations. (1969) (9)
Leukocyte groups and acute leukemia. (1968) (9)
Relationship between postvaccinal anti-influenza antibodies, blood magnesium levels, and HLA antigens. (1985) (9)
Etat actuel de l'immunologie des leucocytes (1957) (9)
HL-A and kidney transplantation. (1972) (9)
Technique de recherche des thrombo-agglutinines immunologiques; influence du chauffage préalable de la suspension plaquettaire. (1958) (9)
Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive Type 1 (insulin-dependent) diabetic patients (1990) (9)
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. (1985) (9)
Immuno-hématologie des leucocytes. (1958) (9)
Les gènes de l'espoir (1994) (9)
Iso-antigènes et iso-anticorps anti-plaquettes (1959) (9)
Third HL-A segregant series: genetic analysis and molecular independence on lymphocyte surface. (1975) (8)
Fifteen years of HL-A: what is the importance of HL-A compatibility for clinical outcome of renal transplantations? (1978) (8)
The challenge of the early days of human histocompatibility (2005) (8)
The Leukoagglutinins (1962) (8)
MHC and general recognition. (1981) (8)
Behavior of HLA-compatible and incompatible skin allografts in human recipients preimmunized with pooled leukocyte extracts obtained from randomly selected donors. (1983) (8)
[Accidents in transfusion]. (1952) (8)
Why Collaboration is Necessary Between Worldwide Bone Marrow Registries. (1996) (8)
Nomenclature for Factors of the HLA System 1984 (1985) (8)
[Presence of A & B antigens in leukocytes disclosed by agglutination tests]. (1954) (8)
HL-A and Burkitt's disease. (2008) (8)
[THE TRANSFER FACTOR]. (1964) (7)
Skin allograft survivals in relation to HL-A incompatibilities and response in MLC. (1973) (7)
Transplacental transmission of natural-killer-cell lymphoma. (1999) (7)
Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens (2004) (7)
The role of HLA-DR antigens in transplantation--survival of skin allografts in HLA-haploidentical donor-recipient combinations. (1978) (7)
Immune platelet isoantibodies. (1960) (7)
Seventh allele of the HLA-C series (Cve). (1979) (7)
[HL-A system in psoriasis; study of 31 families (author's transl)]. (1977) (7)
MHC in general biologic recognition: its theoretical implications in transplantation. (1981) (7)
Matching for hla-dr antigens in renal transplantation. (1979) (7)
HLA-DR-specific suppressor cells after repeated allogeneic sensitizations of human lymphocytes in vitro. (1978) (7)
Le complexe HLA. iv. les associations entre HLA et maladies (1976) (7)
[Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity]. (1997) (7)
[Human histocompatibility]. (1969) (7)
Non-complement-fixing IgM antibodies with anti-HL-A2 specificity and blocking activity. (1973) (7)
Etude statistique et pronostique de 100 cas d’anémie hémolytique immunologique (1958) (7)
Immunological principles of donor selection for human cardiac transplantation. (1969) (6)
Leucocytes, Platelets and Human Homografts: Editorial (1962) (6)
LYMPHOCYTOTOXIC ANTIBODIES AND BONE MARROW GRAFTS FROM HLA‐IDENTICAL SIBLINGS I. HLA ANTIBODIES (1978) (6)
Role of H-2 and non-H-2 genes in the control of blood magnesium levels (2004) (6)
Leucocyte typing versus transformation in mixed lymphocyte culture. (1968) (6)
Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT). (1977) (6)
The preliminary investigation (protocol) of the malformed fetus or neonate--or--what to do until the pathologist comes. (1979) (6)
Etude sérologique d’une agranulocytose allergique à I’aminopyrine (1964) (6)
Maladies malignes identiques au sein d'une même famille (1974) (6)
A systematic study of HLA class II-, 3 DNA restriction fragments in insulin-dependent diabetes mellitus ( histocompatibility antigens / restriction fragment length polymorphism / multigene family ) (6)
Recherche d'une association entre antigènes HL-A et sclérodermie systémique (1975) (6)
Current problems in analysis of results of renal transplantation in man. (1971) (6)
[Studies on transplantation antigens (HL-A) by means of skin grafts from 90 children onto their fathers]. (1969) (6)
Search for DNA sequence variations using a MutS-based technology. (1997) (6)
[Excess of HLA-A2 and HLA-A2 homozygotes in patients with aplastic and Fanconi's anemias]. (1977) (5)
Immunology and genetics of transplantation. (1977) (5)
Detection of HLA-D clusters and segregation studies using primed LD typing. (2008) (5)
Immunisation anti-leucocytaire et anti-plaquettaire provoquée par l'injection répétée du meme sang. (1958) (5)
Enhancement of skin allograft survival in man. (1968) (5)
Role of DL-A system of canine histocompatibility in cardiac transplantation. (1971) (5)
[The ABO system and transplantation. Effect of pre-immunization with soluble A substance]. (1967) (5)
[Role of the ABO erythrocyte system in human histocompatibility]. (1965) (5)
Humoral responses to protozoal infections. (1980) (5)
HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance. (1999) (5)
Associations between restriction fragment length polymorphisms detected with a probe for human 21-hydroxylase (21-OH) and two clinical forms of 21-OH deficiency (1986) (5)
Leucocyte and tissue groups. (1966) (5)
Definition of a New HL‐A Antigen: Da18 (1970) (5)
Use of the Auto-Analyzer to perform serological tests for syphilis. Study of 1,009 sera using a complement fixation test with the cardiolipidic antigen. (1967) (5)
Correlation between an HLA-DQα length polymorphism of messenger RNA and serologically defined specificities (DQwl, DRw53, DR3 + 5) (2004) (5)
Intra HLA recombinations. (1976) (5)
AUTOLYMPHOCYTOTOXIC ANTIBODIES AFTER BONE-MARROW TRANSPLANTATION (1977) (5)
Influence of age and sex upon frequency and cytologic types of human leukemias; evidence of a myeloid: lymphoid antagonism. (1951) (5)
Leucocyte and Tissue Groups 1 (1966) (5)
Génétique du systéme HL-A. Fréquences génique, haplotypique et génotypique observées dans 113 familles. (1969) (5)
Survival-time of Skin Grafts in Rabbits compared with results obtained from an Investigation of Leucocyte Intradermal Tests (1964) (5)
Human Leukocyte Antigen-G: Immunotolerant Major Histocompatibility Complex Molecule in Transplantation (2000) (5)
The search for standard HLA reagents. (2008) (5)
A human anonymous low copy number clone, 4c11 (D6S4), localized to 6p12-6p21, detects 2 RFLPs, one of which is moderately polymorphic. (1987) (5)
Genetic analysis workshop IV: Insulin dependent diabetes mellitus ‐ summary (1986) (4)
Mixed lymphocyte cultures in a family with an LD allele shared by the parents. (2008) (4)
The Diabetic Antigen Glutamic Acid Decarboxylase (GAD 65) in the Human Peripheral Blood (2009) (4)
IgG rheumatoid factor in human and rabbit transplantation sera. (1989) (4)
Insulin-dependent diabetes and HLA. (1979) (4)
Exuberant restriction fragment length polymorphism associated with the DQ a-chain gene and the DX a-chain gene (4)
The long-term fate of cadaver kidney transplants with four defined HL-A antigens (SD1 and SD2 full-house donors): a cumulative case report of 413 consecutive renal allografts from France-Transplant and The London Transplant Group. (1973) (4)
HLA markers in patients suffering from aplastic anaemia. (1981) (4)
Hémagglutination passive des hématies tannées et recouvertes d'une substance plasmatique présente dam la fraction I et ses rapports avec la fibrinolyse ducaillot (1956) (4)
Leucocytes, platelets and human homografts. (1962) (4)
A fragment of the human c-Ki-ras1 pseudogene (HGM9 gene symbol KRAS1P), localized to 6p12-p11, detects 3 allele, RFLP. (1988) (4)
[HL-A system and transplantation]. (1969) (4)
Immunisation croisée entre frères contre des antigènes leucoplaquettaires du système Hu-1. (1967) (4)
Technique de préparation et de transfusion du sang appauvri en leucocytes. (1958) (4)
Role of Ia-like products of the main histocompatibility complex in conditioning skin allograft survival in man. (1979) (4)
[Neonatal thrombopenic purpura with anti-Ko-a feto-maternal isoimmunization]. (1965) (4)
Technique de séparation des leucocytes et des plaquettes à partir du sédiment globulaire mixte recueilli sur les bols des séparateurs centrifuges (1958) (4)
[Immunohematology of platelets and leukocytes]. (1953) (4)
Hémoglobinurie paroxystique à frigore chez un syphilitique guéri par la pénicilline. (1955) (4)
Association of Class I and Class II MHC Restriction Fragment Polymorphism with HLA-Related Diseases (1984) (4)
Abnormal mixed leucocyte reaction in bone marrow aplasia. (1973) (4)
The duration of donor-specific hypersensitivity after human allograft rejection. (1983) (4)
White cells and platelets in tranfusion immunology. (1967) (4)
Relation of antigens Da6 and 6b (Da9) with the antigens of the second sublocus of the HL-A system. (1969) (4)
The HL-A system. Genetic and biological implications. (2009) (4)
[HL-A antigens and predisposition to certain diseases]. (1974) (4)
[Probable linkage between the locus "HLA" and"P"]. (1971) (4)
[Predictive medicine and its ethics]. (1997) (4)
Histocompatibility testing 1972 : report of an international workshop & conference. Colloque de l'Institut national de la santé et de la recherche médicale, held at Evian, France 23-27 May 1972 (1973) (4)
Tissue Typing and Transplantation 1 (1969) (4)
Tissue typing in human transplantation. (1968) (4)
The human Ia equivalent (the Ly-Li system) of the HLA-D region. (1978) (4)
Serological expression after sequential double transfection with purified HLA-11 gene of mouse fibroblasts carrying human beta-2 microglobulin (2004) (4)
Similarities Between the HL‐A System and Other Immunogenetic Systems (1972) (4)
Hematologic Determinants of Human Histocompatibility (1967) (3)
[Identity of leukocytic antigens detectable from immune iso-leuko-agglutinins in monozygotic twins]. (1957) (3)
Advance in transplantation : proceedings of the first International Congress of the Transplantation Society, Paris 27-30 June 1967 (1968) (3)
Regulation of the human allogenic proliferative response in vitro. II. Production of soluble suppressor factors by suppressor T cells and evidence in favor of "acceptor" cells for suppression among unprimed lymphocytes. (1981) (3)
[The biological implications of the main histocompatibility system: the HL-A system]. (1974) (3)
[Genotypic study of HL-A histocompatibility in 91 kidney transplants]. (1969) (3)
[Lymphocyte mixed culture reaction (LMC) between parents and children with the same HL-A phenotype. Hypothesis of a genetic recognition system]. (1972) (3)
Nomenclature for Factors of the HLA System 1977 (1977) (3)
Anti-Leucocyte Cytoplasm, Anti-Leucocyte Nuclei and Anti-Platelets in Disseminated Lupus Erythematosis (1961) (3)
1996 Medawar Prize Lecture. (1997) (3)
LYMPHOCYTOTOXIC ANTIBODIES AFTER BONE MARROW TRANSPLANTATION IN APLASTIC ANEMIA: II. NON‐HLA ANTIBODIES (1980) (3)
HLA-G : un antigène non classique du complexe majeur d'histocompatibilité (1995) (3)
Importance des anticorps anti-leucocytaires et anti-plaquettaires en pratique transfusionnelle (1958) (3)
[Accidents of transfusion in recipients of group A having received group O blood; role of vaccination with diphtheria and tetanus anatoxin]. (1951) (3)
Are there human analogs of the mouse T locus in central nervous system malformations? (1979) (3)
First International Congress of the Transplantation Society (1967) (3)
Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants. (1987) (3)
[Practical use of the auto-analyzer for the serodiagnosis of syphilis (study of 1,009 sera) using a cardiolipid antigen]. (1966) (3)
The Study of Human Ia‐Like Specificities Using Antibody Eluates from Human Lymphoblastoid Cell Lines (1977) (3)
Hla-g Today (3)
[HLA-G: a non classical antigen of major histocompatibility complex]. (1995) (3)
Hémotypes leucocytaires et plaquettaires à définition immunologique (1965) (3)
Difference between γ-Globulins fixed on the Platelets of Patients with Idiopathic Thrombocytopenic Purpura and of those suffering from Disseminated Lupus Erythematosus or a Panhæmatocytopenia (1960) (3)
[Prospects and ethics of predictive medicine]. (1986) (3)
[Polymorphism of HLA genes: I. Demonstration of a close correlation between DNA fragments determined by BglI restriction enzyme and HLA class I antigens]. (1982) (3)
Screening and use of high titered anti-HLA-DR sera in PHA-blast complement fixation and B-lymphocytotoxicity techniques. (2008) (3)
BIOLOGICAL IMPLICATIONS OF TRANSPLANTATION RESEARCH * (1966) (3)
Les gènes α du récepteur des cellules T: une possible implication dans la susceptibilité génétique à la sclérose en plaques (1987) (3)
HLA and non-HLA phenotyping and genotyping in Austral and Gambier Polynesian Archipelagos. (2008) (3)
HISTOCOMPATIBILITY, WITH PARTICULAR REFERENCE TO THE COMPARATIVE IMMUNOGENICITY OF THE MAJOR TRANSPLANTABLE ORGANS* (2003) (3)
Indépendance du système d'histocompatibilité HL-A et des systèmes de groupes des bêta-lipoprotéines Lp et Ag. (1968) (3)
Criminal hazards of human organ traffic. (1996) (3)
WHO‐IUIS TERMINOLOGY COMMITTEE NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM (1976) (3)
DETECTION OF HISTOCOMPATIBILITY ANTIGENS HL-A1, 2, 5, AND 7 ON LEUKOCYTES BY A SIMPLIFIED COMPLEMENT-FIXATION METHOD (1969) (3)
[Presence of a leukoagglutinin in serum of three leukopenic patients]. (1953) (2)
A quantitative evaluation of HL-A gene products. (1974) (2)
An automatic technique for erythrocyte antigen dosage. Preliminary results. (1974) (2)
Some remarks about the preceding paper by Prof. J.J. van Rood with regard to the interpretation of the results of kidney and skin allograft studies in man. (1973) (2)
Computerized system for the selection of the most HLA-compatible kidney recipient (France-Transplant). (1978) (2)
[Hemorrhagic syndromes caused by medicamentous sensitization; present state of the question with reference to a case of thrombopenic purpura caused by 1-acetyl-3-allyl-3-isopropylurea]. (1954) (2)
HLA et maladie de Behcet (1977) (2)
[Antigen Da17: a new antigen of the first sub-locus of the HL-A system]. (1969) (2)
[Study of an active allergic antibody in presence of para-aminosalicylate of sodium (P.A.S.) against human erythrocytes, leukocytes and platelets]. (1960) (2)
Rapports entre l'hémagglutination passive des hématies tannées recouvertes d'extrait plaquettaire et la fibrinolyse dans les cirrhoses du foie. (1956) (2)
Probability of graft compatibility (1970) (2)
Nomenclature for Factors of the HLA System‐1977 1 (1979) (2)
Triplets répétés, maladies neurodégénératives et psychiatriques : mécanismes et gènes candidats. (1996) (2)
Fibrinolyse du sang péripheriquè au cours du flux menstruel physiologique. (1958) (2)
[Indications for transfusion with concentrated or washed erythrocytes]. (1954) (2)
A simulation of HLA-DR matching in kidney transplantation. (2008) (2)
Fréquence des iso-anticorps anti-plaquettaires chez les malades polytransfusés (1962) (2)
Non HLA antigenic determinants expressed on activated T and B human lymphocytes. (2008) (2)
Immunologie des leucocytes. (1956) (2)
La médecine prédictive (1995) (2)
Considérations sur la génétique du système HL-A et ses applications en transplantation (1971) (2)
Human Histocompatibility Antigens (1971) (2)
Allo-immunisation fœto-maternelle anti-leuco-plaquettaire (1969) (2)
[The HL-A W27 antigen. Its incidence in ankylosing spondylarthritis and the Fiessinger-Leroy-Reiter syndrome]. (1974) (2)
[Letter: HL-A groups in juvenile diabetes]. (1976) (2)
[Influence of agitation on agglutination of blood platelets; its usefulness in research on thrombo-agglutinins and in performance of the Coombs blood platelet test; preliminary technical note]. (1954) (2)
Complex MLR family patterns (1975) (2)
Specific immune responses after booster immunization with tetanus toxoid in man: Study of kinetics, family segregation, and linkage to HLA of in vitro lymphocyte proliferative responses and serum-antibody responses (2004) (2)
Acceleration of fibrinolysis of blood-clots by dilution with saline and human serum. (1956) (2)
Predictive medicine. (1996) (2)
Heterogeneity of HLA genetic factors in IDDM susceptibility (2004) (2)
Kinetics and specificity of the secondary MLR and CML. (1976) (2)
[Hematic origin of cirrhoses]. (1951) (2)
Our genetic patrimony. (1994) (2)
Comparison of genetic (factorial correspondence analysis) and geographical distances. (1975) (2)
5th Histocompatibility Workshop. Introduction. (1975) (2)
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness (1994) (2)
Functional study and detection of HLA-D products on fractionated human bone marrow cells. (2008) (2)
[Transfusion of washed or plasma free red cells]. (1952) (2)
Probable role of suppressor cells and factors in kidney graft survival. (1982) (2)
First international symposium on hla and disease. Predisposition to disease and clinical implications. Paris—Palais des Congres—June 23–25, 1976 (1976) (2)
[HL-A and Behcet disease]. (1977) (2)
Qualitative and Quantitative Study of the Antigens and Antibodies of the HL‐A System — Automatic Fluorochrome Method (1975) (2)
[Antileukocyte & antiplatelet immunization induced by repeated injection of the same blood]. (1958) (2)
The experimental skin allograft in man. (1980) (2)
[A new antigen of the system HL-A (Hu-1): the antigen 15, possible allele of the antigens 1, 11, 12]. (1968) (2)
Formal genetics of the HL-A region. (1975) (2)
The Use of the Inverted Microscope in Leuco ‐Agglutination (1963) (2)
Use of synthetic oligonucleotides for genomic DNA dot hybridization to split the DQw3 haplotype. (1988) (2)
Tritiation d'une Anti-γ-globuline et dosage radiochimique (1964) (2)
Transplantation reactions in humans. (1965) (2)
[A LEUKOCYTE GROUP SYSTEM AND ITS RELATIONS WITH HISTOCOMPATIBILITY]. (1965) (2)
[Classification and biologic tests for hemolytic anemias]. (1953) (2)
[Immunohematology and auto-aggressive diseases]. (1953) (2)
[Coincidences or fundamental relationships between leukemogenesis and transplantation antigens]. (1967) (1)
[Are circulating anticoagulants antibodies?]. (1959) (1)
[Acquired hemolytic jaundice specially treated by two exsanguine transfusions; persistence of biological stigmata; clinical stabilization]. (1951) (1)
France-transplant: kidney transplantation as a guide for bone-marrow grafting. (1974) (1)
[Frequency of anti-platelet iso-antibodies in polytransfused patients]. (1962) (1)
[The Hu-1 system. Population and family genetic studies]. (1967) (1)
Production and isolation of HLA-G1 and HLA-G5 soluble proteins in E. coli (1997) (1)
Recombinant DNA Technology: Its Use in the Study of HLA (1984) (1)
Proposal for a world bank of reactive cells from bone marrow. (1974) (1)
[The law of choice of an organ donor for transplantation]. (1969) (1)
A non-complement-fixing antibody, segregating with HL-A3, detected on lymphocytes by immunofluorescence. (1975) (1)
[The HLA complex. IV. Associations between HLA and diseases]. (1976) (1)
Search for a correlation between familial allergy to dactyl (Pollen hypersensitivity) and HLA antigens. (2008) (1)
Search for a correlation between familial allergy to cocksfoot pollen and HLA antigens. (1977) (1)
[Critical study of the remissions in the course of acute leukemia treated by exchange transfusions (comparison with spontaneous remissions and those induced by folic acid antagonists)]. (1950) (1)
[Skin homograft in man in relation to leukocytic iso-antigens]. (1963) (1)
The HLA complex in 1977. (1977) (1)
[Demonstration of the Rh (D) antigen on leukocytes and platelets from humans]. (1958) (1)
HLA-DR-specific human suppressor cells generated by repeated in vitro sensitization against allogeneic cells. (1979) (1)
p21 WAF-1 reorganizes the nucleus in tumor suppression (cancer geneticsychromatin architectureygenome organizationyp53) (1998) (1)
[Study of an allergic antibody active in the presence of sodium p-aminosalicylate (PAS) against human erythrocytes, leukocytes and platelets]. (1961) (1)
[Acute thrombopenic purpura due to antipyrine derivatives]. (1955) (1)
Etude des gènes HLA par les enzymes de restriction (1984) (1)
A subclone of the autosomal phosphoglycerate kinase pseudogene (HGM8 gene symbol PGK1P2), localized to 6p23-q12, detects moderately polymorphic RFLP. (1987) (1)
Regulation of the human allogeneic proliferative response in vitro (2004) (1)
Diagnosis of genetic disease by linkage analysis. (1987) (1)
Descriptive serological analysis. (1975) (1)
[Appearance of a leuko-agglutinin during the course of a case of Hodgkin's disease]. (1954) (1)
[Electrophoresis of the serum proteins in hemolytic anemias with incomplete hot auto-antibodies]. (1953) (1)
[Immunological study in nine cases of Marchiafava-Micheli syndrome]. (1956) (1)
[Predictive medicine: its future]. (2000) (1)
[Acute idiopathic thrombopenic purpura; demonstration in vitro of an antiplatelet agglutinin]. (1953) (1)
HLA-G: a new opening for HLA. (1999) (1)
[Relationships between grafts and leucocytics or thrombocytic antigens in man]. (1965) (1)
[Immunology of leukocytes]. (1955) (1)
[Leuko-agglutinins. IV. Idiopathic chronic pancytopenia with serum leukoagglutinins]. (1953) (1)
[Research technic for immunologic thrombo-agglutinins; influence of previous heating of platelet suspensions]. (1958) (1)
[The direct antiglobulin consumption test with leukocytes and blood platelets from some patients with idiopathic pancytopenias]. (1958) (1)
ON THE BUYING AND SELLING OF ORGANS FOR TRANSPLANTATION (1986) (1)
Serologic factors in human transplantation. Ann. Surg (1968) (1)
[Treatment of bone marrow aplasia by allogenic bone marrow grafts]. (1975) (1)
[Presence of Rh (D) antigen in human leukocytes & platelets]. (1958) (1)
[Technic of preparation and transfusion of blood deprived of leukocytes]. (1958) (1)
The Life and Times of the Human Major Histocompatibility Complex (1993) (1)
[BLOOD DISORDERS INDUCED BY PHENOTHIAZINES]. (1965) (1)
CHAPTER 13 – THE ALLOGENEIC RESPONSE (1976) (1)
The HLA Story (1995) (1)
[Acute post-influenzal hemolytic jaundice]. (1951) (1)
ETHICS OF TISSUE TYPING ON LIVE ORGAN DONORS (1987) (1)
[The HLA complex. 3. Implications in transplantation and transfusion]. (1976) (1)
[Organ grafts. A declaration of the International Transplantation Society]. (1971) (1)
CHIMERISM IN SCLERODERMA. AUTHORS' REPLY (1998) (1)
[Agglutination and destruction in vitro of normal blood platelets by serum from a patient with purpura thrombopenica; inhibition of cloth retraction by serum]. (1952) (1)
[Research of an association between HL-A antigens and systemic scleroderma]. (1975) (1)
Isolation and chemical identification of the transplant antigens in man (1969) (1)
Histocompatibility testing 1972 : report of an Conference and Workshop on Histocompatibility......,1972 (1973) (1)
[Molecular genetics of juvenile diabetes]. (1985) (1)
[Immunological agranulocytosis and leukopenia; serological aspects and general serology of leukocytes]. (1954) (1)
Are D and DR Two Distinct Entities (1981) (1)
Tissue typing today : proceedings of an International Symposium on the Role of Histocompatibility Typing in Clinical Organ Transplantation, February 23-25, 1971, Paris, France (1971) (1)
A study of the HLA-D region in patients with classic Kaposi's sarcoma (2004) (1)
[Prolonged erythroblastopenic episode marking the onset of chronic hemolytic anemia with auto-antibodies]. (1955) (1)
Effects of antigen dose variations upon the response to skin homografts in man—a preliminary report (1966) (1)
[Increased risk of insulin-dependent diabetes for siblings of diabetic children with the DR 3 haplotype of the mother]. (1989) (1)
[Statistical and prognostic study of 100 cases of immunological hemolytic anemia]. (1958) (1)
In memoriam John Marquis Converse, M.D. (1909-1981). (1981) (1)
Human autologous rosette-forming cells. V. Study of MHC control in erythrocyte-lymphocyte interaction. (1986) (1)
[Results of a study of the relationship between the number of pregnancies and the occurrence of acute myeloblastic leukemia]. (1971) (1)
Molecular Genetics of the HLA System: New Tools for the Study of HLA and Disease (1984) (1)
The problem of compatibility in hematology with particular reference to bone marrow transplantation. (1970) (1)
[The main system or systems of tissue groups]. (1966) (1)
Les facteurs Gm(a), Gm(b), Gm(x) au cours des hémopathies malignes (1964) (1)
Hemochromatose idiopathique liaison avec le systemie HLA. (1978) (1)
[HLA and disease]. (1978) (1)
Étude du système inhibiteur de la leucoagglutination (1959) (1)
Transcrits différentiels du gène du CMH de classe I non classique HLA-G dans le trophoblaste de 1er trimestre de gestation et le placenta à terme (1995) (1)
Bioéthique et responsabilité scientifique (1998) (1)
Etude statistique des iso-antigènes leucocytaires (1964) (1)
Identité des antigènes leucocytaires décelables par les iso-leuco-agglutinines immunes chez les jumeaux monozygotes. (1957) (1)
Qu'est-ce que la médecine prédictive ? (1985) (1)
Risque accru de diabète insulino-dépendant pour les germains d'enfants diabétiques ayant reçu l'haplotype DR3 de la mère (1989) (1)
La réaction d'hémagglutination passive des hématies tannées et recouvertes d'extrait plaquettaire ou de fibrinogène et ses rapports avec la fibrinolyse du caillot. (1956) (1)
Les droits de l'homme face aux progrès des connaissances (1989) (1)
L'eau, l'amnagement du territoire et le dveloppement durable (1998) (1)
Modes de vie et cancers : quand la biologie et l'anthropologie s'associent pour traquer le cancer à travers la mosaïque génétique et sociale des groupes humains (2012) (1)
Etude d'une modification de l'expression du locus AB0 chez un sujet 47,XY,(?18q-)+ (1974) (1)
Les cytopénies médicamenteuses (1965) (1)
Demonstration de l'antigène Rh (D) sur les leucocytes et les plaquettes humaines. (1958) (1)
Indications des dérivés du sang dans le traitement des agranulocytoses. (1956) (1)
Vers un avenir réfléchi (1991) (1)
[Isolation and chemical characterization of transplantation antigens in man]. (1968) (1)
[Acute thrombopenic purpura due to phenyldimethylisopropylpyrazolon: demonstration of a serum thromboagglutinin active only in the presence of the drug]. (1954) (1)
[Physiology and pathology of the HLA complex (author's transl)]. (1977) (0)
[Acquired hemolytic anemia]. (1950) (0)
Expression of HLA-G1 and HLA-G2 isoforms on the K562 transfected cells (1997) (0)
For whom is arterial catheterization dangerous (1972) (0)
CEPH Genotype Database Version 10 Released (2005) (0)
[THROMBODYNAMOGRAPHIC PLATELET QUALITATIVE TESTS. CLINICAL AND BIOLOGICAL SIGNIFICANCE IN THROMBOPENIA]. (1963) (0)
MARKETS IN KIDNEYS (1984) (0)
[Fibrinolysis of peripheral blood during physiological menstruation]. (1958) (0)
[Localization in the HLA complex of a gene coding for the B lymphocyte system, Ly-Li]. (1976) (0)
A Role for HLA-Class I Molecules from Accessory Cells in T-Cell Activation (1988) (0)
[Non-identity of gamma globulins fixed in vitro on platelets from certain types of (1) thrombopenic purpura; (2) pancytopenia or disseminated lupus erythematosus]. (1960) (0)
[Not Available]. (1948) (0)
[HL-A and periodic disease]. (1977) (0)
Soluble hla-g containing compositions for the treatment of inflammatory skin diseases (2000) (0)
[Effect of endocrine factors on the antagonism between lymphoid and myeloid leukemias (sex and age factors)]. (1952) (0)
[STATISTICAL STUDY OF LEUKOCYTIC ISO-ANTIGENS. RELATION BETWEEN SKIN GRAFT TOLERANCE AND THE LEUKOCYTE FORMULAS OF DONORS AND RECIPIENTS]. (1964) (0)
[Passive hemagglutination reaction with erythrocytes treated with tannic acid, recovered from platelet extract]. (1955) (0)
[A new example of anti-platelet antibody Ko]. (1963) (0)
[Auto-antibodies in thrombopenic purpura & leukopenia]. (1957) (0)
[Therapy by transfusion in hemolytic anemias]. (1952) (0)
[A new example of anti-platelet antibody Ko]. (1963) (0)
HLA Gene Polymorphism: Class I (1984) (0)
Nomenclature for factors of the HLA system 1984. (1985) (0)
[Immunohematology of hemolytic anemia]. (1954) (0)
Transcriptional regulation of the HLA-G gene: Cell specific nuclear factors bind to a 5′ regulatory element located at 1.1 kb to the translation site of HLA-G gene (1997) (0)
[Acquired hemolytic anemia with hot auto-antibodies]. (1952) (0)
CEPH contribution to the human genome mapping (1995) (0)
Cytolysis Inhibit NK and Antigen-Specific CTL as Nonmature Cell Surface Glycoproteins HLA-G 2 ,-G 3 , and-G 4 Isoforms Expressed (2001) (0)
[Lymphocyte mixed culture. Possible role of the are of the 1st HL-A locus]. (1973) (0)
[Action of anti-platelet immune antibodies on the thromboelastogram]. (1959) (0)
To: Tissue Typing Laboratories (2008) (0)
Difference between gamma-globulins fixed on the platelets of patients with idiopathic thrombocytopenic purpura and of those suffering from disseminated lupus erythematosus or a panhaematocytopenia. (1960) (0)
[Neonatal immunologic thrombopenia]. (1969) (0)
[The HL-A complex considered as an immunological unit]. (1977) (0)
Transplantation Surgery (2001) (0)
[A case of electrical burn with anuria]. (1953) (0)
[Case of acute hemolytic anemia in a young child with presence of immunological hemolysin & anticomplement property of the blood]. (1957) (0)
[Demonstration of a soluble factor capable of inhibiting allogenic lymphocyte proliferation in man]. (1979) (0)
[Detection of a minor stimulating product involved in secondary allogenic proliferation of human lymphocytes in vitro]. (1977) (0)
[Acute hemolytic anemia with auto-antibody acting only on proteolytic enzyme-treated erythrocytes; outline of a possible viral etiology]. (1954) (0)
[Coombs' test]. (1953) (0)
[ACTH and cortisone in immunohematology]. (1953) (0)
The role of the HLA-D (D and DR) locus in the rejection of allografts. (1980) (0)
[Case report of acquired agammaglobulinemia in an adult with splenomegaly]. (1957) (0)
Tribute to Roy Walford (2004) (0)
Important role of HLA-A, B, DR matching on graft survival in 305 presensitized patients (1982) (0)
The search for standard HLA reagents. (1976) (0)
THE HISTORY OF SKIN TRANSPLANTATION (2003) (0)
Allocution de Jean Dausset lors du cinquantenaire de la publication princeps sur le HLA (2003) (0)
[Disorders of the blood composition in acute leukemias; biological and therapeutic study]. (1950) (0)
[Hemolytic anemia and their treatment]. (1954) (0)
[Aspecific immunological hemolysins; conditions of systematic detection]. (1954) (0)
Immunology 80, Fourth International Congress of Immunology. (1980) (0)
[Abolition of delayed hypersensitivity reactions and the severity of aplasia induced by rubidomycin]. (1967) (0)
Introduction - : Ouverture de séance (1997) (0)
Greffe de moelle osseuse dans les aplasies médullaires (1977) (0)
Specificities shared between HLA-A3 and HLA-A11 detected by Fab'2 blocking (1976) (0)
QUELQUES REMARQUES SUR LES CYTOP'ENIES M'EDICAMENTEUSES IMMUNOLOGIQUES. (1964) (0)
[Bioethics and predictive medicine]. (1993) (0)
[Apparently acquired neuro-hemolytic disease; presence of circulating antibodies of the incomplete type; influence of exchange transfusions; remarkable results of splenectomy on hemolysis and neurological disorders]. (1951) (0)
[The HLA complex. II. Immunogenetics of the HLA system. The allelic HLA-D series and the specificities of lymphocyte subpopulations]. (1976) (0)
[Attempt to differentiate the diverse varieties of acute leukemia by examination of fresh blood and bone marrow]. (1950) (0)
Un système complexe : impacts et prévisions. Modélisations appliquées à la région méditerranéenne (1999) (0)
Détection du polymorphisme des gènes HLA de classe II à l'aide d'oligonucléotides de synthèse (1985) (0)
GROUPES 'ERYTHROCYTAIRES ET PATHOLOGIE. (1965) (0)
[Cross immunization between brothers against the leukocyte and platelet antigens of the Hu-1 system]. (1967) (0)
[Genetics of the HL-A system. Haplotype and genotype gene frequencies observed in 113 families]. (1969) (0)
[The Atri system. Immunogenetic lymphocytic system associated with ABO and ABH secretory systems]. (1976) (0)
[Antiplatelet antibodies]. (1959) (0)
Relationship between passive hemagglutination of tanned red cells coated with fraction I and fibrinolysis in cirrhosis of the liver (1956) (0)
Tolérance fœto-maternelle : Rôle des molécules HLA-G présentes à la surface des cellules trophoblastiques : Colloque : Cellules embryonnaires et trophoblastiques : Adhésion et migration (1998) (0)
Study on the influence of the rhesus system on skin graft survival. (1972) (0)
ORGANIZATION, DIVERSITY AND REARRANGEMENT OF THE HUMAN T-CELL REARRANGING GAMMA-GENES (1986) (0)
[Recent progress made in the choice of donor in transplantation]. (1968) (0)
[Immuno-hematology of leukocytes]. (1958) (0)
[Anemia in acute leukosis]. (1955) (0)
[Detection of incomplete antibodies by the technic of erythrocytes trypsinized and utilized in plasma medium]. (1950) (0)
Nomenclature for factors of the HLA system-1977. (1978) (0)
[Association France-Transplant]. (1973) (0)
[The hemodialysis-transplantation association makes possible yearly economizing of hospital costs]. (1975) (0)
[Cold paroxysmal hemoglobinuria in a syphilitic cured by penicillin]. (1955) (0)
[HL-A haplotypes in 56 patients with classical rheumatoid polyarthritis seen at the Viggo Peterson Center]. (1980) (0)
[Detection of polymorphism of HLA class II genes using synthetic oligonucleotides]. (1985) (0)
[SPECIFICITY DISTINCTIONS IN ALLERGIC ANTI-PAS ANTIBODIES]. (1964) (0)
Transplantation and humanism in the new millenium. (2001) (0)
[Medicine: 15 centuries of real progress?]. (1986) (0)
[Drug hazards related to hereditary constitution. Hematological accidents]. (1971) (0)
[Thrombopenic purpuras of chemical origin; antagonism of allergic and toxic mechanisms]. (1954) (0)
MLR INHIBITION, HLA-D TYPING USING HOMOZYGOUS TYPING CELLS AND IN “VITRO” PRIMED LYMPHOCYTES VERSUS A B CELL SPECIFIC ANTIGENIC SYSTEM (1977) (0)
The HLA system and the rheumatic diseases. (1982) (0)
Individuality and determinism: Chemical and Biological Bases, par S.W. Fox, 225 p. (Plenum Press, New York), 1984, $ 35 (1984) (0)
[Gametic association in the HL-A chromosomal region (an argument in favor of gene flow by migration)]. (1973) (0)
[Isoantibodies and antigens of leukocytes and platelets independent of those of erythrocytes]. (1959) (0)
[Relation between passive hemagglutination and erythrocytes treated with tannin obtained from thrombocyte extracts and fibrinolysis in liver cirrhosis]. (1956) (0)
[Close genetic relation between determinants coding for the HLA-D region, detected by the technique of mixed primary and secondary lymphocyte culture and by serology of B lymphocytes]. (1977) (0)
[Passive hemagglutination reaction of platelets tanned and coated with platelet extract or fibrinogen and its relation to fibrinolysis of the clot]. (1956) (0)
[Acceleration of fibrinolysis of the blood clot by dilution and by addition of human serum]. (1956) (0)
[Hemolysins in hemolytic anemia and hemoglobinuria]. (1952) (0)
[The association France-Transplant]. (1973) (0)
Use of compositions containing soluble forms of HLA-G in the treatment of inflammatory diseases of the skin, and process for obtaining them (1999) (0)
Corrélation entre le polymorphisme de taille des ARN messagers (mRLP), alpha HLA-DQ et la série MT (DRw52 et 53) (1985) (0)
Une nouvelle aventure biologique : la transplantation (1968) (0)
[Preponderant role of the 2nd HL-A locus (or of a linked gene) in the lymphocyte mixed culture reaction]. (1971) (0)
Selection of HLA-G expressing tumors, can be treated by anticancer agents, and their uses (1999) (0)
[A study on the lymphocyte structure that control cell-mediated allogeneic response (mixed lymphocyte culture): HLA-D locus (author's transl)]. (1977) (0)
[Hormone therapy of malignant blood diseases and their immunologic complications by formation of auto-antibodies]. (1953) (0)
[Hemolytic hypersplenic anemia]. (1952) (0)
[Biological definition of self]. (1982) (0)
[Mode of action of a soluble restricted factor, a suppressor of the allogeneic proliferative response in man]. (1980) (0)
[IMMUNOLOGIC STUDIES OF PATIENTS WITH PLACENTAL CHORIO-EPITHELIOMA]. (1965) (0)
[The French Transplantation Association. II. Kidney transplantats between donors and recipients grouped in the HL-A system. French statistics]. (1972) (0)
AUTOIMMUNE HÆMOLYTIC ANÆMIA WITH ACUTE RENAL FAILURE DUE TO PHENACETIN AND P.A.S. (1960) (0)
[II. Serological study of 12 cases of acquired hemolytic anemia with auto-antibodies]. (1951) (0)
[The different varieties of thrombo-agglutinins]. (1957) (0)
Vers l'Homme responsable (2004) (0)
Polymorphic restriction endonucle; correlates with the gene for HLA-B (polymorphism) (2016) (0)
[New facts regarding the immunological aspects of leukocytes]. (1957) (0)
Comparison of the Genetics of H-2 and HL-A Systems1 (1971) (0)
[Criteria for selection of donors of organs]. (1968) (0)
The use of the inverted microscope in leuco-agglutination. (1963) (0)
[A FEW REMARKS ON IMMUNOLOGICAL MEDICAMENTOUS CYTOPENIA]. (1964) (0)
[Definition of 2 new antigens of the HL-A system: Da 19 and Da 20. Cross reactions between the Da 19, Da 20, HL-A 5 and Da 6 antigens]. (1969) (0)
Milan Hašek: In Memoriam (1989) (0)
The study of human Aa-like specificities using antibody eluates from human lymphoblastoid cell lines. (1977) (0)
[The ABO system and transplantation. Effect of preimmunization with the soluble substances B and H]. (1969) (0)
[Bone marrow transplants in bone marrow aplasias]. (1977) (0)
[Letter: Identical malignant diseases in members of the same family]. (1974) (0)
The chromosomal HL-A complex. Humoral and cellular immunity in organ graft rejection. (1973) (0)
Le complexe HLA considr comme une unit immunologique (1977) (0)
[The place of bleeding time in the current exploration of thrombopenia]. (1963) (0)
[Secretion and absorption on O erythrocytes of the Atri substance]. (1974) (0)
SURVIVAL OF FRATERNAL SKIN ALLOGRAFT (1966) (0)
[Research technic of leukocyte agglutination]. (1956) (0)
[Detection of presence of antigens A and B in human leukocytes by absorption test]. (1955) (0)
[Studies on thromboagglutinins by the agitation method]. (1955) (0)
[Idiopathic hemochromatosis linkage with the HLA system (author's transl)]. (1978) (0)
[Linkage between the HL-A histocompatibility system and the thymidine kinase activity in a human-mouse hybrid]. (1972) (0)
[Thrombopenias and leukopenias caused by auto-immunization]. (1965) (0)
[Hemolytic anemias of plasmatic origin]. (1951) (0)
An immunochemical study of the lymphocyte A, Atri system. (1980) (0)
[TRITIATION OF AN ANTI-GAMMA GLOBULIN AND RADIOCHEMICAL DOSIMETRY]. (1964) (0)
[Problem of auto-antibodies]. (1958) (0)
[Hemolytic anemia in an adult with atrophic cirrhosis, a complex nervous syndrome and Gougerot-Sjögren syndrome]. (1951) (0)
[Anti-leukocyte and platelet iso- and autoantibodies]. (1963) (0)
A method and apparatus for distributing a primary volume of liquid in a certain number of secondary volumes, which have a certain relationship to each other. (1988) (0)
[THE GM(A), GM(B), AND GM(X) FACTORS IN MALIGNANT BLOOD DISEASES]. (1964) (0)
[Immunology of blood platelets]. (1955) (0)
[Redistribution of HL-A antigens induced by antibody fixation to cell membrane]. (1972) (0)
Tissue Typing: Symposium organized by the International Society of Blood Transfusion at the 10th Congress of the European Society of Haematology, Strasbourg, August 1965 (1966) (0)
[Setting-up a national file of bone marrow volunteer donors]. (1987) (0)
Allosensitized T cells produce soluble factors susceptible to suppress allogeneic proliferation but not to interfere on cell mediated cytotoxicity. (1981) (0)
[The theoretical and practical importance of the association between HLA and disease]. (1979) (0)
[STUDY OF NEW SERUM GROUPS BY MEANS OF "INDIVIDUAL ANTIGLOBULINS"]. (1963) (0)
[Disseminated lupus erythematosus discovered during delivery: a difficult diagnosis]. (1992) (0)
Hepatoblastoma and thyroid carcinoma co-segregate with congenital hypertrophy of the retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (1998) (0)
[Acquired hemolytic anemia with auto-antibodies: evolution, prognosis and treatment based on 54 cases]. (1954) (0)
[Anti-leukocyte and antiplatelet iso-antibodies. Serology and practical importance, especially for grafts]. (1962) (0)
[Repeated exchange transfusions in therapy of anuric nephritis]. (1951) (0)
[Study of the HLA system and glyoxalase in 31 insulin-dependent diabetics free from micro and macro-angiopathies after more than a 20-year development]. (1989) (0)
In reply to Sir Michael Woodruff. The question of the expression of mouse H-2 isoantigens and human HL-A isoantigens on red cells. (1969) (0)
[Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants]. (1980) (0)
[Current status of leukocyte immunology]. (1957) (0)
[Results of treatment of anuric nephritis by exchange transfusions; statistics on 95 cases]. (1950) (0)
[Elimination of certain transfusional shocks by using leukocyte deficient blood]. (1957) (0)
Isolation from the Human MHC of a Class I Gene Encoding a Nonubiquitous Antigen Expressed on Activated Cells (1989) (0)
Allelic Class II Determinants Defined by PLT Typing (1984) (0)
[Immunological anemia, leukopenia and thrombopenia; combination of antibodies against the three cellular components of the blood]. (1954) (0)
[Combined use of radioiron and differential hemagglutination in study of hemoglobin metabolism in circulating erythrocytes]. (1954) (0)
Le complexe chromosomique HL (1973) (0)
Données actuelles sur les possibilités de la chimiothérapie dans les carcinomes utérins (1988) (0)
[Immunology of leukocytes]. (1955) (0)
Médicaments et allaitement maternel (1987) (0)
[Not Available]. (1947) (0)
Compositions contenant des formes solubles d'hla-g dans le traitement de pathologies inflammatoires de la peau (2000) (0)
AIDS agreement (1987) (0)
[Value of a lympho-platelet adherence test in the chronic idiopathic thrombopenic purpuras]. (1972) (0)
Lettre de Jean DUSSET, président du MURS (1989) (0)
Use of synthetic oligonucleotides for genomic DNA dot hybridization to split the DQw 3 haplotype ( restriction fragment length polymorphism ) (0)
Relations entre les greffes et les antigènes leucocytaires ou plaquettaires chez l’homme* (1965) (0)
[Study of the level of total complement in the course of various blood diseases]. (1959) (0)
[Anemias due principally to hemolysis]. (1959) (0)
[The major OLA histocompatibility complex of sheep. Recent results in the genetic study of 11 factors previously defined by microlymphocytotoxicity]. (1978) (0)
[HLA groups in the infantile psychoses during development, and hypothesis for an enzyme defect]. (1977) (0)
[Study of the inhibitory factor of leuko-agglutination]. (1954) (0)
[The anemias. V. Hemolytic anemia]. (1956) (0)
The HL-A complex in kidney transplantation. (1974) (0)
[Acquired hemolytic anemia in adult with atrophic cirrhosis, complex nervous syndrome and Gougerot-Sjogren syndrome]. (1952) (0)
Procede et dispositif de repartition d'un volume primaire de fluide en un nombre determine de volumes secondaires presentant une relation predefinie entre eux (1988) (0)
method for selecting at least one screen for mutations, its application to a method for rapid identification of alleles of polymorphic systems and device for its implementation óoeuvre. (1991) (0)
[Not Available]. (1956) (0)
Recherche d'anticorps antilymphocytaires dans le sérum de 67 enfants atteints d'arthrite chronique juvénile. (1980) (0)
"Guerre et paix, singularite de l'espece humaine" : Une approche parmi d'autres possibles (1986) (0)
Letter: HL-A and pernicious anemia. (1975) (0)
[Correlation between the expression of HL-A and P systems antigens in hybrid human x mouse cells and culture media (HATG, Standard, BUDR). Possible linkage of HL-A and P loci with the thymidine kinase locus]. (1973) (0)
L’aspect sérologique in vitro des anticorps anti-leucocytaires (1956) (0)
Génétique moléculaire du diabète juvénile. (1985) (0)
Anaemia, Leucopenia and Thrombocytopenia Due to Drug Allergy: the Importance of Cross‐Reactions (2008) (0)
des raisons d'espérer (1987) (0)
[Renal transplantation. Immunologic basis of HL-A system]. (1969) (0)
Vivre avec les radiations (1988) (0)
Hematologic determinants of human histocompatibility. (1967) (0)
[Research on the inhibitory properties of agglutination by Newcastle disease virus in sera of patients with acquired hemolytic anemia and other hemolytic syndromes]. (1952) (0)
Le système Atri. Système immunogénétique lymphocytaire associé au système de groupe ABO et au système de sécrétion ABH (1976) (0)
Lymphocytic regulation by antibodies, par C. Bona et P. A. Cazenave, 324 p. (Interscience, Wiley, Chichester, Sussex) £ 28,25. (1981) (0)
[NEONATAL AGRANULOCYTOSIS AND GRANULOPENIA CAUSED BY FETO-MATERNAL ISOIMMUNIZATION]. (1964) (0)
Technique de recherche des autohémolysines immunologiques. (1957) (0)
Odd page (2004) (0)
Les grossesses hétérotopiques. A propos d'une observation de grossesse intra-utérine associée à une grossesse extra-utérine chez une femme porteuse d'un stérilet (1987) (0)
Lhomme responsable de l'homme (1988) (0)
James Van Gundia Neel, papers, ca. 1935-1999 (2014) (0)
[ANTI-PLATEGLET ISO-ANTIBODIES REVEALED BY COMPLEMENT FIXATION]. (1964) (0)
[Not Available]. (1957) (0)
Löslische hla-g containing zusammensetsungen for treating inflammatory skin diseases (2000) (0)
Les nouvelles responsabilités face à la vie (1992) (0)
[Isoimmune neonatal thrombocytopenic purpuras]. (1965) (0)
[Immunology of thrombocytes]. (1954) (0)
[The hemorrhagic syndrome of acute leukemias]. (1950) (0)
[Hemolytic jaundice in malignant diseases (leukemias, malignant granulomatoses, cancer)]. (1952) (0)
Acquisition de nouvelles connaissances science et technologie : les responsabilités (1998) (0)
[Gm(a), Gm(b) and Gm(x) factors during leukoses]. (1962) (0)
[Not Available]. (1947) (0)
HLA-G mRNA alternatively spliced forms that may encoded at least five distinct molecules on the cell surface (1997) (0)
La différence : nécessité biologique et richesse culturelle (1986) (0)
«Environnement atmosphérique et devenir de l'Homme» : constitution d'un groupe de réflexion (1991) (0)
[So-called acquired agammaglobulinemia in an adult with splenomegaly]. (1957) (0)
Importance théorique et pratique des associations entre HLA et maladies. (1979) (0)
[The Ly-Li system, a new locus of the HLA complex]. (1977) (0)
[Independence of the histocompatibility system HL-A and the systems of the beta-lipoprotein groups Lp and Ag]. (1968) (0)
[Technic for separating leukocytes and blood platelets from the blood cell mixture sedimented in the separating centrifuge]. (1958) (0)
[SEROLOGICAL STUDY OF ALLERGIC AGRANULOCYTOSIS CAUSED BY AMINOPYRINE]. (1964) (0)
Un organisme français au coeur du projet génome : le CEPH (1990) (0)
La définition et la reconnaissance du soi (1981) (0)
[Organ transplantation in France in 1984 (activity report of France-Transplant)]. (1986) (0)
Greffes d'organes. Une déclaration de la Société Internationale de Transplantation. (1971) (0)
[Not Available]. (1946) (0)
HLA-G et échappement des cellules tumorales à la surveillance immunitaire (1999) (0)
[Genetic and immunologic factors in human leukemogenesis]. (1970) (0)
[IMMUNOLOGICAL REACTIONS IN THE COURSE OF IDIOPATHIC THROMBOPENIC PURPURA]. (1964) (0)
[Medicinal cytopenias]. (1964) (0)
[I. Clinical and hematological study of 12 cases of acquired hemolytic anemia with auto-antibodies]. (1951) (0)
[The impossible divorce or two branches of medicine]. (1953) (0)
D-aspartate schizophrénie (2015) (0)
HLA-G1 and HLA-G2 act as ligands recognized by a yet-unknown natural killer inhibitory receptor(s) (1997) (0)
[Critical examination of immunological methods used in the study of thrombopenic purpuras]. (1957) (0)
[Indications for blood derivatives in therapy of agranulocytosis]. (1956) (0)
Study of HL‐A Genotypes in a Case of Familial Chronic Lymphocytic Leukaemia (CLL) (2008) (0)
[Anti-leukocyte and anti-platelet feto-maternal allo-immunization]. (1969) (0)
[Anemia caused by extra-erythrocyte disorders. (Hemolytic anemia caused by antoantibodies)]. (1967) (0)
[The HL-A chromosome complex]. (1973) (0)
[Relationship between the number of pregnancies and the risk of acute leukemia]. (1970) (0)
[Calculation of the desirable number of waiting future recipients of organ transplants]. (1969) (0)
[Platelet antibodies]. (1958) (0)
Leucocyte group studies in renal transplant candidates. (1968) (0)
HLA-G : une molécule de tolérance (1998) (0)
[Antiplatelet auto-antibodies & immunological tests]. (1959) (0)
Regulation and modulation of classical HLA class I gene transcription in trophoblast cells and choriocarcinoma JEG-3 cells (1997) (0)
[Determination by three technics of cellular immunology of the antigenic determinants of the Ly-Li system expressed on human B lymphocytes]. (1976) (0)
[Serological techniques with auto-antibodies in acquired hemolytic anemias]. (1951) (0)
[Identification of leukocytic antigens and their significance for clinical transplantation and hematology. 3. Specificity of Hu-1 antibodies in antileukocytic serums]. (1969) (0)
[Clinical aspects of immunohematology; diseases of auto-aggression]. (1952) (0)
[Problems of antileukocytic antibodies]. (1956) (0)
Le M.U.R.S. aujourd'hui et demain (1986) (0)
Transfusion at the municipal level. (1946) (0)
Class II HLA-DC , 8-chain DNA restriction fragments differentiate among HLA-DR 2 individuals in insulin-dependent diabetes and multiple sclerosis ( histocompatibility antigens / restriction fragment length polymorphism / multigene family / gene conversion ) (2003) (0)
Conclusion des travaux synthèse et résolutions (1997) (0)
The Pharmacology of Immunoregulation, par Werner Flock, 459 p. (Academic Press, London) £ 16.50. (1979) (0)
[Value of the use of human serum as a source of complement in a complement fixation reaction on platelet antigens]. (1968) (0)
[The definition and recognition of oneself]. (1981) (0)
[ERYTHROCYTE GROUPS AND PATHOLOGY]. (1965) (0)
Some Considerations on HLA and Malignancies (1983) (0)
Bioéthique génétique : médecine prédictive (1995) (0)
An approach to the facilitation of skin allograft survival in man. (1966) (0)
[Search for antilymphocytic antibodies in the serum of 67 children with juvenile chronic arthritis]. (1980) (0)
L’action in vivo des anticorps antileucocytaires et anti-plaquettaires (1956) (0)
Occurrence ofT-Cell Features in a Child's Lymphoproliferative Disorder1 (1984) (0)
[The second sub-locus of the HL-A system]. (1968) (0)
[Editorial: HL-A and diseases]. (1974) (0)
Recombinant interferon a can induce rearrangement of T-cell antigen receptor a-chain genes and maturation to (0)
[Genetics of the HL-A system and its applications in transplantation]. (1971) (0)
[Plasma factors of hemolysis]. (1962) (0)
[Genetic markers and disease susceptibility (author's transl)]. (1979) (0)
[A new dimension of the Hippocraticoath]. (1974) (0)
[A new biologic adventure: the transplantation]. (1968) (0)
Le premier atelier (workshop) international du grand projet génome humain : le CEPH (1990) (0)
[Hla genotype and familial psoriasis]. (1976) (0)
Theme 12: summary. Effector and escape mechanisms in host-parasite relationships. (1980) (0)
[Genetic effect on specific human immune responses to tetanus anatoxin]. (1983) (0)
[Anti-leukocyte and anti-platelet immunization and transfusions during aplastic anemias]. (1976) (0)
Cloning and Expression of the Gene Encoding HLA-A11 (1984) (0)
No 1, série A, édité par P. Cuatrecasas and M. F. Greaves (Chapman and Hall, 11 New Fetter Lane — London E.C. 4P. 4EE). (1976) (0)
Fundamental immunology: par W.E. Paul, 1 Vol., 829 p. (Ed Raven Press, New York) 1984, $ 99,50 (1984) (0)
Le rôle des antigènes de groupes sanguins en histocompatibilité humaine et en particulier des antigènes du système Hu-1 (1968) (0)
Evaluation of mixed lymphocyte cultures according to changes in the lymphocyte nucleoli. (1968) (0)
[Statistical study of the results of kidney transplants organized by "France-Transplant"]. (1973) (0)
Perspectives et éthique de la médecine prédictive. (1986) (0)
[Familial studies on leuko-platelet allo-antigens]. (1967) (0)
[HL-A histocompatibility and renal grafts. France-Transplant Statistics]. (1974) (0)
Joint Report of the B Lymphocyte Specificities Workshop of the France‐one Region by FRANCE‐ONE with the collaboration of (2008) (0)
[The HL-A complex as a functional unit]. (1974) (0)
Theme 12. Effector and escape mechanisms in host-parasite relationships. (1980) (0)
[Acquired hemolytic anemia]. (1950) (0)
[Hypothesis concerning the evolution of the HL-A system]. (1974) (0)
[New source of leukocytes and platelets; mixed globular sediment collected on the centrifuge bowls]. (1958) (0)

This paper list is powered by the following services:

Other Resources About Jean Dausset

en.wikipedia.org

What Schools Are Affiliated With Jean Dausset?

Jean Dausset is affiliated with the following schools:

Image Attributions

Image Source for Jean Dausset